Alert: Ipca Laboratories UK various products

Ipca Laboratories UK Ltd has advised that the Patient Information Leaflet (PIL) in the products listed below do not contain all the required safety information.

This issue impacts all current batches of the impacted products. Please see detailed information regarding the missing information in each PIL below.

Dispensary teams are asked to signpost patients on these medicines to the missing safety information in the PIL.

Hard copies of the updated PIL are available from quality@ipcauk.com

Product quality is not impacted and patients should continue to take these medicines as prescribed.

MHRA alert

Latest news

England & Wales: initial August concession price update

The Department of Health and Social Care has published an initial update to the initial list of August concessions. In this update, there are 48 new prices DDA members can download a fully updated spreadsheet of the Aug

New CD guidance for limited companies

The DDA and the Healthcare Distribution Association (HDA) has published joint guidance on the supply of Controlled Drugs to GP practices constituted as a limited company. In summary, two core regulatory requirements apply: Care regulator registra

Dispensing cross subsidy highlighted in rural GP funding critique

The role of dispensing income as a cross subsidy for rural NHS GP funding has been highlighted in a new paper by a think-tank. Noting the funding challenges of delivering NHS GP services in rural areas, General practice funding in England publ

Alert: Ipca Laboratories UK various products

Latest news

England & Wales: initial August concession price update

New CD guidance for limited companies

Dispensing cross subsidy highlighted in rural GP funding critique

View all news

Gold Supporters

Follow us

Dispensing Doctors' Association

DDA Best Practice Group

Dispensing Doctors' Association